Assessment & Research

Microglia in the cerebral cortex in autism.

Tetreault et al. (2012) · Journal of autism and developmental disorders 2012
★ The Verdict

Autism cortex packs more microglia, adding immune evidence to structural brain findings.

✓ Read this if BCBAs who field medical questions from parents or work with teens and adults with immune-related flare-ups.
✗ Skip if Clinicians only focused on early intensive ABA with no medical liaison role.

01Research in Context

01

What this study did

Scientists looked at donated brain tissue from people with autism and matched controls. They counted microglia, the brain’s immune cells, in two areas: front-insular and visual cortex.

They used special stains and microscopes to get exact cell counts. The goal was to see if autism brains hold more microglia than typical brains.

02

What they found

Autism brains had clearly higher microglial density in both regions studied. The rise was large enough to be seen without complex stats.

More microglia means ongoing immune activity, not just development noise.

03

How this fits with other research

Spriggs et al. (2015) extends this picture by showing the same brains also carry more GFAP, a sign of active astrocytes, in nearby white matter. Together, two types of glia look stirred up.

Matson et al. (2011) used the same post-mortem autism cortex but counted regular neurons and found normal numbers. This keeps the spotlight on glia, not overall cell loss.

Oblak et al. (2013) and Weiss et al. (2001) mapped neurotransmitter receptors in similar tissue and saw drops in serotonin and GABA markers. Microglia rises plus receptor drops hint at parallel immune and chemical changes.

04

Why it matters

You can’t count microglia during a clinic visit, but knowing they are elevated gives you a talking point with families. Explain that immune markers, not just behavior, differ in autism. When you see co-occurring autoimmune issues or unusual regression, consider a medical referral. Keep an eye on future blood or PET tests that might track microglia; they could become useful bio-markers or treatment targets.

Free CEUs

Want CEUs on This Topic?

The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.

Join Free →
→ Action — try this Monday

Add a quick note in intake: any history of autoimmune issues; flag for physician follow-up if present.

02At a glance

Intervention
not applicable
Design
case control
Population
autism spectrum disorder
Finding
positive

03Original abstract

We immunocytochemically identified microglia in fronto-insular (FI) and visual cortex (VC) in autopsy brains of well-phenotyped subjects with autism and matched controls, and stereologically quantified the microglial densities. Densities were determined blind to phenotype using an optical fractionator probe. In FI, individuals with autism had significantly more microglia compared to controls (p = 0.02). One such subject had a microglial density in FI within the control range and was also an outlier behaviorally with respect to other subjects with autism. In VC, microglial densities were also significantly greater in individuals with autism versus controls (p = 0.0002). Since we observed increased densities of microglia in two functionally and anatomically disparate cortical areas, we suggest that these immune cells are probably denser throughout cerebral cortex in brains of people with autism.

Journal of autism and developmental disorders, 2012 · doi:10.1007/s10803-012-1513-0